3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Anemia, Sickle Cell
1
Interventions
Cyclophosphamide
4
fludarabine phosphate
3
fludarabine
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Melphalan
2
Fentanyl
2
Busulfan
2
Alemtuzumab
2
AP 1903 reagent
2
voxelotor
1
thymoglobulin
1
maltodextrin
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Medical Marijuana
1
Imagery, Psychotherapy
1
Holistic Health
1
Glutamine
1
Dexamethasone
1
Bortezomib
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anemia, Sickle Cell
×
voxelotor
×
Clear all
NCT03036813
2023-07-27
GBT_HOPE
Pfizer
Phase 3
Completed
449 enrolled
17 charts
1 FDA